Mark J. Alles - Jun 2, 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Stock symbol
TPTX
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 05:34 PM
Previous filing
May 26, 2021
Next filing
Jun 10, 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +209 $0.00 209 Jun 2, 2021 Common Stock 209 $65.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest on the one-year anniversary of the date of grant.